These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 34092632)

  • 1. Cerebrospinal Fluid Sulfatide Levels Lack Diagnostic Utility in the Subcortical Small Vessel Type of Dementia.
    Svensson J; Blomqvist M; Kettunen P; Eckerström C; Henricsson M; Jonsson M; Bjerke M; Månsson JE; Wallin A
    J Alzheimers Dis; 2021; 82(2):781-790. PubMed ID: 34092632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients with the Subcortical Small Vessel Type of Dementia Have Disturbed Cardiometabolic Risk Profile.
    Axelsson E; Wallin A; Svensson J
    J Alzheimers Dis; 2020; 73(4):1373-1383. PubMed ID: 31929169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low cerebrospinal fluid sulfatide predicts progression of white matter lesions: The LADIS study.
    Jonsson M; Zetterberg H; Rolstad S; Edman A; Gouw AA; Bjerke M; Lind K; Blennow K; Pantoni L; Inzitari D; Wallin A
    Dement Geriatr Cogn Disord; 2012; 34(1):61-7. PubMed ID: 22922641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid biomarkers of white matter lesions - cross-sectional results from the LADIS study.
    Jonsson M; Zetterberg H; van Straaten E; Lind K; Syversen S; Edman A; Blennow K; Rosengren L; Pantoni L; Inzitari D; Wallin A
    Eur J Neurol; 2010 Mar; 17(3):377-82. PubMed ID: 19845747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid markers of pathogenetic processes in vascular dementia, with special reference to the subcortical subtype.
    Wallin A; Blennow K; Rosengren L
    Alzheimer Dis Assoc Disord; 1999; 13 Suppl 3():S102-5. PubMed ID: 10609688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulfatide as a biochemical marker in cerebrospinal fluid of patients with vascular dementia.
    Fredman P; Wallin A; Blennow K; Davidsson P; Gottfries CG; Svennerholm L
    Acta Neurol Scand; 1992 Feb; 85(2):103-6. PubMed ID: 1574982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurofilament protein in cerebrospinal fluid: a marker of white matter changes.
    Sjögren M; Blomberg M; Jonsson M; Wahlund LO; Edman A; Lind K; Rosengren L; Blennow K; Wallin A
    J Neurosci Res; 2001 Nov; 66(3):510-6. PubMed ID: 11746370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid neurofilament light chain is a marker of aging and white matter damage.
    Meeker KL; Butt OH; Gordon BA; Fagan AM; Schindler SE; Morris JC; Benzinger TLS; Ances BM
    Neurobiol Dis; 2022 May; 166():105662. PubMed ID: 35167933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical markers in vascular cognitive impairment associated with subcortical small vessel disease - A consensus report.
    Wallin A; Kapaki E; Boban M; Engelborghs S; Hermann DM; Huisa B; Jonsson M; Kramberger MG; Lossi L; Malojcic B; Mehrabian S; Merighi A; Mukaetova-Ladinska EB; Paraskevas GP; Popescu BO; Ravid R; Traykov L; Tsivgoulis G; Weinstein G; Korczyn A; Bjerke M; Rosenberg G
    BMC Neurol; 2017 May; 17(1):102. PubMed ID: 28535786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between intrathecal sulfatide and TNF-alpha levels in patients with vascular dementia.
    Tarkowski E; Tullberg M; Fredman P; Wikkelsö C
    Dement Geriatr Cogn Disord; 2003; 15(4):207-11. PubMed ID: 12626853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSF sulfatide distinguishes between normal pressure hydrocephalus and subcortical arteriosclerotic encephalopathy.
    Tullberg M; Månsson JE; Fredman P; Lekman A; Blennow K; Ekman R; Rosengren LE; Tisell M; Wikkelsø C
    J Neurol Neurosurg Psychiatry; 2000 Jul; 69(1):74-81. PubMed ID: 10864607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid cytoskeleton proteins in patients with subcortical white-matter dementia.
    Wallin A; Sjögren M
    Mech Ageing Dev; 2001 Nov; 122(16):1937-49. PubMed ID: 11589912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study.
    Fortea J; Carmona-Iragui M; Benejam B; Fernández S; Videla L; Barroeta I; Alcolea D; Pegueroles J; Muñoz L; Belbin O; de Leon MJ; Maceski AM; Hirtz C; Clarimón J; Videla S; Delaby C; Lehmann S; Blesa R; Lleó A
    Lancet Neurol; 2018 Oct; 17(10):860-869. PubMed ID: 30172624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The neurofilament heavy chain (NfH) in the cerebrospinal fluid diagnosis of Alzheimer's disease.
    Brettschneider J; Petzold A; Schottle D; Claus A; Riepe M; Tumani H
    Dement Geriatr Cogn Disord; 2006; 21(5-6):291-5. PubMed ID: 16484807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased cerebrospinal fluid neurofilament light chain in central nervous system inflammatory demyelinating disease.
    Peng L; Bi C; Xia D; Mao L; Qian H
    Mult Scler Relat Disord; 2019 May; 30():123-128. PubMed ID: 30771578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid sulfatide is decreased in subjects with incipient dementia.
    Han X; Fagan AM; Cheng H; Morris JC; Xiong C; Holtzman DM
    Ann Neurol; 2003 Jul; 54(1):115-9. PubMed ID: 12838527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal Fluid Biomarkers in Patients with Frontotemporal Dementia Spectrum: A Single-Center Study.
    Abu-Rumeileh S; Mometto N; Bartoletti-Stella A; Polischi B; Oppi F; Poda R; Stanzani-Maserati M; Cortelli P; Liguori R; Capellari S; Parchi P
    J Alzheimers Dis; 2018; 66(2):551-563. PubMed ID: 30320576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid β-amyloid
    Osborn KE; Liu D; Samuels LR; Moore EE; Cambronero FE; Acosta LMY; Bell SP; Babicz MA; Gordon EA; Pechman KR; Davis LT; Gifford KA; Hohman TJ; Blennow K; Zetterberg H; Jefferson AL
    Neurobiol Aging; 2018 Aug; 68():18-25. PubMed ID: 29702372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The age-dependent associations of white matter hyperintensities and neurofilament light in early- and late-stage Alzheimer's disease.
    Walsh P; Sudre CH; Fiford CM; Ryan NS; Lashley T; Frost C; Barnes J;
    Neurobiol Aging; 2021 Jan; 97():10-17. PubMed ID: 33070094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulfatide isoform pattern in cerebrospinal fluid discriminates progressive MS from relapsing-remitting MS.
    Novakova L; Singh AK; Axelsson M; Ståhlman M; Adiels M; Malmeström C; Zetterberg H; Borén J; Lycke J; Cardell SL; Blomqvist M
    J Neurochem; 2018 Aug; 146(3):322-332. PubMed ID: 29676479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.